Jakob Kaminski, Felix Machleid, Caspar Wiegmann, Jan Philipp Klein, Orestis Rakitzis, Raoul Haaf, Stefanie Schreiter, Maximilian Preiß, Lukas Pezawas, Ingrid Titzler
{"title":"[德国抑郁症的数字健康应用:证据的叙述性审查和纳入治疗]。","authors":"Jakob Kaminski, Felix Machleid, Caspar Wiegmann, Jan Philipp Klein, Orestis Rakitzis, Raoul Haaf, Stefanie Schreiter, Maximilian Preiß, Lukas Pezawas, Ingrid Titzler","doi":"10.1007/s00115-025-01879-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Digital technologies open up new opportunities in the treatment of mental health disorders. Internet-based and mobile telephone-based interventions (IMIs), in particular, have proven to be effective, cost-efficient and accessible approaches to improving the care of people with mental disorders. In Germany digital health applications (DiGAs) that are reimbursed by all public health insurances are gaining increasing importance in routine clinical practice.</p><p><strong>Objective: </strong>This article provides a narrative review of the evidence and challenges related to DiGAs for depression in the German healthcare system. The approved DiGAs are presented and key studies, developments and perspectives for future research and care concepts are discussed.</p><p><strong>Material and methods: </strong>This study is based on a narrative review of the relevant literature. The focus is on evidence-based DiGAs approved by the Federal Institute for Drugs and Medical Devices (BfArM) for the treatment of depression and their integration into routine care as well as acceptance by patients and clinicians.</p><p><strong>Results: </strong>Internet-based cognitive behavioral therapy (iCBT) in particular, demonstrate a small to medium effect strength for depression, comparable to face-to-face therapy (Hedge's g = 0.43). Guided and blended care approaches appear to provide advantages with respect to the evidence and care; however, the utilization of DiGAs remains low, considering the large number of affected individuals, which is attributable to factors, such as limited awareness, complex access routes and prescription processes and data privacy concerns.</p><p><strong>Conclusion: </strong>Despite promising evidence, the integration of DiGAs into existing healthcare systems remains challenging. Future research efforts should focus on the long-term effectiveness, personalization of digital solutions and hybrid care models to enhance acceptance and utilization.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"432-438"},"PeriodicalIF":1.1000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411576/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Digital health applications for depressive disorders in Germany : A narrative review of the evidence and integration into treatment].\",\"authors\":\"Jakob Kaminski, Felix Machleid, Caspar Wiegmann, Jan Philipp Klein, Orestis Rakitzis, Raoul Haaf, Stefanie Schreiter, Maximilian Preiß, Lukas Pezawas, Ingrid Titzler\",\"doi\":\"10.1007/s00115-025-01879-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Digital technologies open up new opportunities in the treatment of mental health disorders. Internet-based and mobile telephone-based interventions (IMIs), in particular, have proven to be effective, cost-efficient and accessible approaches to improving the care of people with mental disorders. In Germany digital health applications (DiGAs) that are reimbursed by all public health insurances are gaining increasing importance in routine clinical practice.</p><p><strong>Objective: </strong>This article provides a narrative review of the evidence and challenges related to DiGAs for depression in the German healthcare system. The approved DiGAs are presented and key studies, developments and perspectives for future research and care concepts are discussed.</p><p><strong>Material and methods: </strong>This study is based on a narrative review of the relevant literature. The focus is on evidence-based DiGAs approved by the Federal Institute for Drugs and Medical Devices (BfArM) for the treatment of depression and their integration into routine care as well as acceptance by patients and clinicians.</p><p><strong>Results: </strong>Internet-based cognitive behavioral therapy (iCBT) in particular, demonstrate a small to medium effect strength for depression, comparable to face-to-face therapy (Hedge's g = 0.43). Guided and blended care approaches appear to provide advantages with respect to the evidence and care; however, the utilization of DiGAs remains low, considering the large number of affected individuals, which is attributable to factors, such as limited awareness, complex access routes and prescription processes and data privacy concerns.</p><p><strong>Conclusion: </strong>Despite promising evidence, the integration of DiGAs into existing healthcare systems remains challenging. Future research efforts should focus on the long-term effectiveness, personalization of digital solutions and hybrid care models to enhance acceptance and utilization.</p>\",\"PeriodicalId\":49770,\"journal\":{\"name\":\"Nervenarzt\",\"volume\":\" \",\"pages\":\"432-438\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411576/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nervenarzt\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00115-025-01879-7\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nervenarzt","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00115-025-01879-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:数字技术为精神健康障碍的治疗开辟了新的机会。特别是基于互联网和基于移动电话的干预措施,已被证明是改善对精神障碍患者护理的有效、具有成本效益和可获得的方法。在德国,由所有公共健康保险报销的数字健康应用(DiGAs)在常规临床实践中越来越重要。目的:这篇文章提供了证据和挑战相关的diga抑郁症在德国医疗保健系统的叙述回顾。本文介绍了已获批准的diga,并讨论了未来研究和护理概念的关键研究、发展和前景。材料与方法:本研究基于对相关文献的叙述性回顾。重点是由联邦药物和医疗器械研究所(BfArM)批准用于治疗抑郁症的循证diga,并将其纳入常规护理,并为患者和临床医生所接受。结果:特别是基于互联网的认知行为疗法(iCBT),对抑郁症表现出小到中等的效果强度,与面对面治疗相当(Hedge's g = 0.43)。指导和混合护理方法似乎在证据和护理方面具有优势;然而,考虑到受影响的个人数量众多,diga的利用率仍然很低,这可归因于诸如意识有限、访问路线和处方流程复杂以及数据隐私问题等因素。结论:尽管有令人鼓舞的证据,但将数字数据分析整合到现有医疗保健系统中仍然具有挑战性。未来的研究应关注数字化解决方案的长期有效性、个性化和混合护理模式,以提高患者的接受度和利用率。
[Digital health applications for depressive disorders in Germany : A narrative review of the evidence and integration into treatment].
Background: Digital technologies open up new opportunities in the treatment of mental health disorders. Internet-based and mobile telephone-based interventions (IMIs), in particular, have proven to be effective, cost-efficient and accessible approaches to improving the care of people with mental disorders. In Germany digital health applications (DiGAs) that are reimbursed by all public health insurances are gaining increasing importance in routine clinical practice.
Objective: This article provides a narrative review of the evidence and challenges related to DiGAs for depression in the German healthcare system. The approved DiGAs are presented and key studies, developments and perspectives for future research and care concepts are discussed.
Material and methods: This study is based on a narrative review of the relevant literature. The focus is on evidence-based DiGAs approved by the Federal Institute for Drugs and Medical Devices (BfArM) for the treatment of depression and their integration into routine care as well as acceptance by patients and clinicians.
Results: Internet-based cognitive behavioral therapy (iCBT) in particular, demonstrate a small to medium effect strength for depression, comparable to face-to-face therapy (Hedge's g = 0.43). Guided and blended care approaches appear to provide advantages with respect to the evidence and care; however, the utilization of DiGAs remains low, considering the large number of affected individuals, which is attributable to factors, such as limited awareness, complex access routes and prescription processes and data privacy concerns.
Conclusion: Despite promising evidence, the integration of DiGAs into existing healthcare systems remains challenging. Future research efforts should focus on the long-term effectiveness, personalization of digital solutions and hybrid care models to enhance acceptance and utilization.
期刊介绍:
Der Nervenarzt is an internationally recognized journal addressing neurologists and psychiatrists working in clinical or practical environments. Essential findings and current information from neurology, psychiatry as well as neuropathology, neurosurgery up to psychotherapy are presented.
Review articles provide an overview on selected topics and offer the reader a summary of current findings from all fields of neurology and psychiatry.
Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange.
Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.